Research ExplorerPublicationsMortality and morbidity after cytoreductive nephrectomy for ...

Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.

Standard

Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. / Abdollah, Firas; Sun, Maxine; Thuret, Rodolphe; Schmitges, Jan; Shariat, Shahrokh F; Perrotte, Paul; Montorsi, Francesco; Karakiewicz, Pierre I.

In: ANN SURG ONCOL, Vol. 18, No. 10, 10, 2011, p. 2988-2996.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Abdollah, F, Sun, M, Thuret, R, Schmitges, J, Shariat, SF, Perrotte, P, Montorsi, F & Karakiewicz, PI 2011, 'Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.', ANN SURG ONCOL, vol. 18, no. 10, 10, pp. 2988-2996. <http://www.ncbi.nlm.nih.gov/pubmed/21499808?dopt=Citation>

APA

Abdollah, F., Sun, M., Thuret, R., Schmitges, J., Shariat, S. F., Perrotte, P., Montorsi, F., & Karakiewicz, P. I. (2011). Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. ANN SURG ONCOL, 18(10), 2988-2996. [10]. http://www.ncbi.nlm.nih.gov/pubmed/21499808?dopt=Citation

Vancouver

Abdollah F, Sun M, Thuret R, Schmitges J, Shariat SF, Perrotte P et al. Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. ANN SURG ONCOL. 2011;18(10):2988-2996. 10.

Bibtex

@article{a7a8d933eac14d5d9014fc9996a239ec,
title = "Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.",
abstract = "To test whether the rates of in-hospital mortality, complications, and transfusions are higher in patients treated with cytoreductive nephrectomy (CNT) for metastatic renal cell carcinoma (mRCC) relative to patients treated with nephrectomy (NT) for non-mRCC.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Survival Rate, Follow-Up Studies, Postoperative Complications, Carcinoma, Renal Cell/epidemiology/*mortality/secondary/*surgery, Florida/epidemiology, Hospital Mortality/*trends, Kidney Neoplasms/epidemiology/*mortality/pathology/*surgery, *Morbidity, Nephrectomy/*mortality, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Prognosis, Survival Rate, Follow-Up Studies, Postoperative Complications, Carcinoma, Renal Cell/epidemiology/*mortality/secondary/*surgery, Florida/epidemiology, Hospital Mortality/*trends, Kidney Neoplasms/epidemiology/*mortality/pathology/*surgery, *Morbidity, Nephrectomy/*mortality",
author = "Firas Abdollah and Maxine Sun and Rodolphe Thuret and Jan Schmitges and Shariat, {Shahrokh F} and Paul Perrotte and Francesco Montorsi and Karakiewicz, {Pierre I}",
year = "2011",
language = "English",
volume = "18",
pages = "2988--2996",
journal = "ANN SURG ONCOL",
issn = "1068-9265",
publisher = "Springer New York",
number = "10",

}

RIS

TY - JOUR

T1 - Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.

AU - Abdollah, Firas

AU - Sun, Maxine

AU - Thuret, Rodolphe

AU - Schmitges, Jan

AU - Shariat, Shahrokh F

AU - Perrotte, Paul

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I

PY - 2011

Y1 - 2011

N2 - To test whether the rates of in-hospital mortality, complications, and transfusions are higher in patients treated with cytoreductive nephrectomy (CNT) for metastatic renal cell carcinoma (mRCC) relative to patients treated with nephrectomy (NT) for non-mRCC.

AB - To test whether the rates of in-hospital mortality, complications, and transfusions are higher in patients treated with cytoreductive nephrectomy (CNT) for metastatic renal cell carcinoma (mRCC) relative to patients treated with nephrectomy (NT) for non-mRCC.

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Survival Rate

KW - Follow-Up Studies

KW - Postoperative Complications

KW - Carcinoma, Renal Cell/epidemiology/mortality/secondary/surgery

KW - Florida/epidemiology

KW - Hospital Mortality/trends

KW - Kidney Neoplasms/epidemiology/mortality/pathology/surgery

KW - Morbidity

KW - Nephrectomy/mortality

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Prognosis

KW - Survival Rate

KW - Follow-Up Studies

KW - Postoperative Complications

KW - Carcinoma, Renal Cell/epidemiology/mortality/secondary/surgery

KW - Florida/epidemiology

KW - Hospital Mortality/trends

KW - Kidney Neoplasms/epidemiology/mortality/pathology/surgery

KW - Morbidity

KW - Nephrectomy/mortality

M3 - SCORING: Journal article

VL - 18

SP - 2988

EP - 2996

JO - ANN SURG ONCOL

JF - ANN SURG ONCOL

SN - 1068-9265

IS - 10

M1 - 10

ER -